4.2 Article

Fecal transplant: A safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2013.03.003

关键词

Fecal transplantation; Donor feces infusion; Bacteriotherapy; Intestinal microbiota transfer; Treatment; Probiotics; Autoimmune disease; Cardiovascular disease; Insulin resistance; Clostridium difficile

资金

  1. TIFN [GH-003 2011]
  2. Netherlands Organization for Health Research and Development
  3. Dutch Heart Foundation (ZonMW, VEMI) [170881001]
  4. Dutch Heart Foundation (ZonMW, VENI) [016096044]
  5. Dutch Heart Foundation (CVON)

向作者/读者索取更多资源

Recent studies have suggested an association between intestinal microbiota composition and human disease, however causality remains to be proven. With hindsight, the application of fecal transplantation (FMT) does indeed suggest a causal relation between interfering with gut microbiota composition and a resultant cure of several disease states. In this review, we aim to show the available evidence regarding the involvement of intestinal microbiota and human (autoimmune) disease. Moreover, we refer to (mostly case report) studies showing beneficial or adverse effects of fecal transplantation on clinical outcomes in some of these disease states. If these findings can be substantiated in larger randomized controlled double blind trials also implementing gut microbiota composition before and after intervention, fecal transplantation might provide us with novel insights into causally related intestinal microbiota, that might be serve as future diagnostic and treatment targets in human disease. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据